In Vitroanti-Hiv and Cytotoxicological Evaluation of the Triple Combination: AZT and ddC With HIV Proteinase Inhibitor Saquinavir (Ro 31-8959)

Antiviral Chemistry and Chemotherapy - United Kingdom
doi 10.1177/095632029400500605
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

HIV With Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy

Science
MultidisciplinaryPhilosophy of ScienceHistory
1989English

Neurodevelopmental/Neuroradiologic Recovery of a Child Infected With HIV After Treatment With Combination Antiretroviral Therapy Using the HIV-Specific Protease Inhibitor Ritonavir

Pediatrics
Child HealthPediatricsPerinatology
1998English

Regulatory Dysfunction of the Interleukin-2 Receptor During HIV Infection and the Impact of Triple Combination Therapy

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1998English

From NIH: Study of AZT Effectiveness in Treating HIV-infected Children Halted

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1995English

Activities of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Inhibitor Nelfinavir Mesylate in Combination With Reverse Transcriptase and Protease Inhibitors Against Acute HIV-1 Infection in Vitro.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1997English

Rational Design of Peptide-Based HIV Proteinase Inhibitors

Science
MultidisciplinaryPhilosophy of ScienceHistory
1990English

The Combination of CXCL9, CXCL10 and CXCL11 Levels During Primary HIV Infection Predicts HIV Disease Progression

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Combination Therapy With AZT, FOM, for Infections in the Field of Otorhinolaryngology.

Practica Otologica
Otorhinolaryngology
1990English

Triple Worm Infestation in an HIV-infected Patient

Infection
MedicineInfectious DiseasesMicrobiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy